Implantation of CardioWest total artificial heart for irreversible acute myocardial infarction shock

Heart Surgery Forum

Volumn 10, Issue 4, 2007, Pages 218-223

  Morshuis, M ^a   Reiss, Nils ^a   Arusoglu, L ^a   Tenderich, G ^a   Korfer R ^a   El Banayosy, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICOUMAROL;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; ARTIFICIAL HEART; CARDIOGENIC SHOCK; CLINICAL ARTICLE; EMBOLISM; FEMOROFEMORAL BYPASS; HEART LUNG MACHINE; HUMAN; INTESTINE NECROSIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT INDICATION; ARTIFICIAL HEART PACEMAKER; BLOOD FLOW; CASE REPORT; HEART ASSIST DEVICE; HEART INFARCTION; HEMOFILTRATION; IMPLANTATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTHESIS;

ADULT; AGED; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HEMOFILTRATION; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; REGIONAL BLOOD FLOW; SHOCK, CARDIOGENIC;

EID: 34547917227     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20070706     Document Type: Article

References (33)

1. Allen BS, Buckberg GD, Fontan FM, et al. 1993. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg 105:864-84.
2. Alonso DR, Scheidt S, Post M, Killip T. 1973. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical pathologic and electrocardiographic correlations. Circulation 48:588-96.
3. Arabia FA, Copeland JG, Pavie A, Smith RG. 1999. Implantation technique for the CardioWest Total Artificial Heart. Ann Thorac Surg 68:698-704.
4. Bengtson JR, Kaplan AJ, Pieper KS, et al. 1992. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 20:1482-9.
5. Berger PB, Holmes DR Jr, Stebbins AL, Bates EF, Califf RM, Topol EJ. 1997. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial. An observational study. Circulation 96:122-7.
6. Beyersdorf F, Sarai K, Wendt T, Eckel L, Schneider M, Kubitzky W. 1990. Prolonged abnormalities of LV regional wall motion after reperfusion of patients with preoperative cardiogenic shock. Thorac Cardiovasc Surg 38:165-74.
7. Chen JM, DeRose JJ, Slater JP, et al. 1999. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol 33:1903-8.
8. Copeland JG, Pavie A, Duveau D, et al. 1996. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993-1995. J Heart Lung Transplant 15:94-9.
9. GISSI-2 The International Study Group. 1990. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet 336:71-5.
10. Goldberg RS, Gare JM, Alpert JS, et al. 1997. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from community-wide perspective, 1975-1988. N Engl J Med 325:1117-22.
11. Grines CL, Topol EJ, Califf RM, et al. 1989. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation 80:245-53.
12. Gruppo Italiano per lo Studio della Streptochinasi nell Ínfarto Miocardio (GISSI). 1986. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397-402.
13. Gunnar RM. 1988. Cardiogenic shock complicating myocardial infarction. Circulation 78:1508-10.
14. Harnarayan C, Bennett MA, Pentecost BL, Brewer DB. 1970. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J 32:728-32.
15. Hill JD, Farrar DJ, Hershon JJ, et al. 1986. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 314:626-8.
16. Holmes DR Jr, Bates ER, Kleiman NS, et al. 1995. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. J Am Coll Cardiol 3:668-74.
17. Farrar DJ, Lawson JH, Litwak P, Cederwall G. 1990. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 9:415-23.
18. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. 1993. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 87:500-11.
19. Körfer R, El-Banayosy A, Posival H, et al. 1995. Mechanical circulatory support: the Bad Oeynhausen experience. Ann Thorac Surg 59:56-63.
20. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW. 1991. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long term survival. J Am Coll Cardiol 17:599-603.
21. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. 1992. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 19:907-14.
22. Moritz A, Wolner E. 1993. Circulatory support with shock due to acute myocardial infarction. Ann Thorac Surg 55:238-44.
23. Mueller HS. 1994. Role of intra-aortic counterpulsation in cardiogenic shock and acute myocardial infarction. Cardiology 84:168-74.
24. Noda H, Takano H, Taenaka Y, et al. 1989. Treatment of acute myocardial infarction with cardiogenic shock using left ventricular assist device. Int J Artif Organs 12:175-9.
25. Page DL, Caulfield JB, Kastor JA, DeSanctis RW, Sanders CA. 1971. Myocardial changes associated with cardiogenic shock. N Engl J Med 285:133-7.
26. Park JP, Nguyen DQ, Bank AJ, Ormaza S, Bolman RM 3rd. 2000. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg 69:1146-51.
27. Raithel SC, Swartz MT, Braun PR, et al. 1989. Experience with an emergency resuscitation system. ASAIO Trans 35:475-7.
28. Reedy JE, Swartz MT, Raithel SC, Szukalski EA, Pennington DG. 1990. Mechanical cardiopulmonary support for refractory cardiogenic shock. Heart Lung 19:514-23.
29. Reichman RT, Joyo CI, Dembitzky WP, et al. 1990. Improved patient survival after cardiac arrest using a cardiopulmonary support system. Ann Thorac Surg 49:101-5.
30. Reiß N, Posival H, El-Banayosy A, Schröfel H, Minami K, Körfer R. 1995. Einsatz verschiedener mechanischer Kreislaufunterst,- tzungssysteme in der Therapie des kardiogenen Schocks nach akutem Myokardinfarkt. Z Kardiol 84(suppl 1):20.
31. Vogt A, Neuhaus KL. 1999. Therapie des akuten Myokardinfarkts - Primäre PTCA oder Thrombolyse? Herz 24:363-8.
32. Zeymer U, Reissig M, Neuhaus KL. 1993. Einsatz einer perkutan anschließbaren Herz-Lungen-Maschine unter Reanimationsbedingungen im kardiogenen Schock bei akutem Herzinfarkt. Dtsch Med Wochenschr 118:1755-8.
33. Zumbro GL, Kitchens WR, Shearer G, Harville G, Bailey L, Galloway RF. 1987. Mechanical assistance for cardiogenic shock following cardiac surgery, myocardial infarction and cardiac transplantation. Ann Thorac Surg 44:11-3.